Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand. Ngiwsara L, Wattanasirichaigoon D*, Tim-Aroon T, Rojnueangnit K, Noojaroen S, Khongkraparn A, Sawangareetrakul P, Ketudat-Cairns JR, Charoenwattanasatien R, Champattanachai V, Kuptanon C, Pangkanon S, Svasti J. BMC Med Genet. 2019 Sep 11;20(1):156.

01 Sep 2019
0
0

Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand.

Ngiwsara L, Wattanasirichaigoon D*, Tim-Aroon T, Rojnueangnit K, Noojaroen S, Khongkraparn A, Sawangareetrakul P, Ketudat-Cairns JR, Charoenwattanasatien R, Champattanachai V, Kuptanon C, Pangkanon S, Svasti J.

BMC Med Genet. 2019 Sep 11;20(1):156.

Tags

Share this

Related Posts

A validated LC-MS/MS method for clinical pharmacokinetics and presumptive phase II metabolic pathways following oral administration of Andrographis paniculata extract. Songvut P, Pholphana N, Suriyo T, Rangkadilok N, Panomvana D, Puranajoti P, Satayavivad J. Sci Rep. 2023 Feb 13;13(1):2534.
13 Feb 2023
0

A validated LC-MS/MS method for clinical pharmacokinetics and presumptive phase II metabolic pathways following oral administration of Andrographis paniculata extract. Songvut P, Pholphana N, Suriyo T, Rangkadilok N, Panomvana D, Puranajoti P, Satayavivad J. Sci Rep. 2023 Feb 13;13(1):2534.

A validated LC-MS/MS method for clinical pharmacokinetics and presumptive phase II metabolic pathways following oral administration of Andrographis paniculata extract. Songvut P, Pholphana N, Suriyo T, Rangkadilok N, Panomvana D, Puranajoti P, Satayavivad J. Sci Rep. 2023 Feb 13;13(1):2534.
View More

Recent Posts